SCHEMBL30558043

SCHEMBL30558043

CCOC(=O)c1c(Cl)nc(SC)nc1C=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.41
▸ LMNA P02545 4/20 0.41
▸ TSHR P16473 3/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ POLB P06746 2/20 0.38
▸ HPGD P15428 2/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ HTT P42858 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25366055 1.00 MAPT (0.41) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL537829 0.88 MAPT (0.48) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL30558079 0.88 MAPT (0.40) MAPTLMNATSHRNPSR1MAPK1
SCHEMBL25365589 0.88 MAPT (0.40) MAPTLMNATSHRNPSR1MAPK1
SCHEMBL26620710 0.86 SMN1; SMN2 (0.42) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL30726179 0.86 SMN1; SMN2 (0.42) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL1298575 0.82 LMNA (0.44) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL31207902 0.82 LMNA (0.44) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL31207901 0.82 LMNA (0.44) MAPTLMNATSHRSMN1; SMN2NPSR1
SCHEMBL25365319 0.82 SMN1; SMN2 (0.39) MAPTLMNATSHRSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4486454-A1 COMPOUNDS GlaxoSmithKline Intellectual Property Development Limited (GB) 2025-01-08 — — EP disclosed
WO-2023156648-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-08-24 — — WO disclosed
Send feedback